CD4+ T-cell receptor (TCR) (TCR)

Human CD4+ T-cell receptors (TCRs) are membrane-bound heterodimeric proteins, typically composed of alpha and beta chains, that play a central role in the adaptive immune system by recognizing specific antigenic peptides (UniProt: P01848). In the context of viral infections like influenza, these receptors identify epitopes derived from proteins such as hemagglutinin (HA) when they are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (PubMed: 25148029). This recognition event triggers a complex intracellular signaling cascade via the associated CD3 complex, leading to the activation, proliferation, and differentiation of CD4+ T helper cells (NCBI: NBK27146). These activated T cells are essential for orchestrating the immune response, including the provision of help to B cells for high-affinity antibody production and the modulation of cytotoxic T-cell activity (PubMed: 30247452). While these TCRs are the primary targets for induction by seasonal and universal influenza vaccines, they are also being explored as direct targets for engineered TCR-T cell therapies aimed at providing broad protection against diverse viral strains (PubMed: 29103912). Pharmacological agents such as cyclosporine and tacrolimus are used to modulate TCR-mediated signaling in various clinical settings, while safety concerns include the potential for cytokine release syndrome and autoimmune reactions due to molecular mimicry (StatPearls: T-cell Receptors).

Other names

T-cell antigen receptorTCR complexAlpha-beta T-cell receptorCD3-TCR complexMHC class II-restricted T-cell receptor

The TCR complex recognizes specific viral peptides presented on MHC class II molecules, initiating a signaling cascade through the CD3 subunits and ZAP-70 kinase, which results in T-cell activation, proliferation, and the orchestration of the adaptive immune response against the virus.